Patent · US Active

PD-1 antibody, antigen-binding fragment thereof, and medical application thereof

US11365255B2 · kind B2 · utility

0Cited by

28References

12Claims

0Family size

Assignees

Inventors

Jijun Yuan · Shanghai, CN
Xiangdong QU · Shanghai, CN
Jufang Lin · Shanghai, CN
Xin Ye · Beijing, CN
Guoqing CAO · 安丰镇, CN
Weikang Tao · Shanghai, CN
Lianshan Zhang · 安丰镇, CN
Lei Zhang · Beijing, CN
Li Yang · Shanghai, CN

Key dates

Filing date	May 30, 2019
Grant date	Jun 21, 2022
Priority date	—
Expiry date	Feb 1, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a human PD-1 antibody, an antigen-binding fragment thereof, and medical use thereof, and further provides a chimeric antibody and humanized antibodies comprising a complementarity-determining region (CDR) of the antibody, a pharmaceutical composition comprising the human PD-1 antibody and the antigen-binding fragment thereof, and use of the antibody in preparing medicines for treating diseases or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.